|
Code
|
7247C
|
|
MA number
|
EU/1/18/1271/003
|
|
Product Form:
|
sol inj 1x0,7 ml/105 mg (liek.inj.skl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Roche Registration GmbH, Germany
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B02 |
ANTIHEMORRHAGICS |
| B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
| B02BX |
Other systemic hemostatics |
| B02BX06 |
Emicizumab |
|
|
Shelf life:
|
24 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
